SCHEMBL4152229

SCHEMBL4152229

CN(C)CCN1CCn2c(c([C@H]3CCCC[C@@H]3F)c3ccc(C(=O)O)cc32)-c2ccc(Cl)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.40
MMP12 P39900 1/20 0.40
GLP1R P43220 2/20 0.36
CSNK2A1 P68400 1/20 0.33
SRD5A1 P18405 1/20 0.32
SRD5A2 P31213 1/20 0.32
TERT O14746 3/20 0.32
DRD2 P14416 3/20 0.32
ESR1 P03372 3/20 0.31
ESR2 Q92731 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
KCNH2 Q12809 1/20 0.30
ERCC1 P07992 1/20 0.30
ERCC4 Q92889 1/20 0.30
PLD1 Q13393 1/20 0.30
HTR1A P08908 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4152231 1.00 PRKCA (0.40) PRKCAMMP12GLP1RCSNK2A1SRD5A1
SCHEMBL4161492 0.93 PRKCA (0.34) PRKCAMMP12GLP1RSRD5A1SRD5A2
SCHEMBL4161495 0.93 PRKCA (0.34) PRKCAMMP12GLP1RSRD5A1SRD5A2
SCHEMBL4140597 0.92 PRKCA (0.40) PRKCAMMP12GLP1RCSNK2A1DRD2
SCHEMBL4140592 0.92 PRKCA (0.40) PRKCAMMP12GLP1RCSNK2A1DRD2
SCHEMBL4152405 0.92 PRKCA (0.40) PRKCAMMP12CSNK2A1ESR1
SCHEMBL4152401 0.92 PRKCA (0.40) PRKCAMMP12CSNK2A1ESR1
SCHEMBL4152321 0.91 KCNH2 (0.35) PRKCAMMP12SRD5A1SRD5A2DRD2
SCHEMBL4152317 0.91 KCNH2 (0.35) PRKCAMMP12SRD5A1SRD5A2DRD2
SCHEMBL4152682 0.90 PRKCA (0.39) PRKCAMMP12ESR1MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136449-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-05-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136449-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, ZC3HAV1 PRKCA 4320/4885MMP12 3563/4885GLP1R 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.